Penumbra (PEN) Accounts Payables (2014 - 2026)
Penumbra's (PEN) quarterly Accounts Payables came in at $43.7 million in Q1 2026, up 40.14% year-on-year from $31.2 million in Q1 2025, and up 25.69% on a QoQ basis from $34.7 million in Q4 2025.
Penumbra (PEN) Accounts Payables (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Accounts Payables data on file, last reported at $43.7 million in Q1 2026.
- On a quarterly basis, Accounts Payables rose 40.14% year-over-year to $43.7 million in Q1 2026; TTM through Mar 2026 was $43.7 million, a 40.14% increase from a year earlier, with the FY2025 full-year figure at $34.7 million, up 10.89% from the prior year.
- Accounts Payables for Q1 2026 stood at $43.7 million, up from $34.7 million in the prior quarter.
- Over the last five years, Accounts Payables for PEN reached as high as $43.7 million in Q1 2026 and fell as low as $14.1 million in Q1 2022.
- Historically, Accounts Payables has averaged $29.2 million across 5 years, with a median of $28.2 million in 2023.
- Across the five-year window, Accounts Payables jumped 99.47% in 2023 and declined 14.32% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $26.7 million in 2022, then increased by 1.78% to $27.2 million in 2023, then increased by 15.36% to $31.3 million in 2024, then climbed by 10.89% to $34.7 million in 2025, then advanced by 25.69% to $43.7 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $43.7 million in Q1 2026, $34.7 million in Q4 2025, and $29.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.33 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.18 Bn |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 43.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.66 Mn |
| Dec 31, 2025 | 34.74 Mn |
| Sep 30, 2025 | 29.82 Mn |
| Jun 30, 2025 | 28.12 Mn |
| Mar 31, 2025 | 31.15 Mn |
| Dec 31, 2024 | 31.33 Mn |
| Sep 30, 2024 | 33.15 Mn |
| Jun 30, 2024 | 32.82 Mn |
| Mar 31, 2024 | 32.45 Mn |
| Dec 31, 2023 | 27.16 Mn |
| Sep 30, 2023 | 28.00 Mn |
| Jun 30, 2023 | 25.82 Mn |
| Mar 31, 2023 | 28.20 Mn |
| Dec 31, 2022 | 26.68 Mn |
| Sep 30, 2022 | 25.37 Mn |
| Jun 30, 2022 | 23.10 Mn |
| Mar 31, 2022 | 14.14 Mn |
| Dec 31, 2021 | 13.42 Mn |
| Sep 30, 2021 | 13.68 Mn |
| Mar 31, 2021 | 15.39 Mn |